Thenalidine
Thenalidine is an antihistamine with anticholinergic properties used as an antipruritic drug.[1] It was withdrawn from the US, Canadian, and UK markets in 1963 due to a risk of neutropenia.[2]
Clinical data | |
---|---|
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number |
|
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.001.501 |
Chemical and physical data | |
Formula | C17H22N2S |
Molar mass | 286.436 g/mol g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
|
References
- Getzler, N. A.; Ereaux, L. P. (1959). "Evaluation of thenalidine tratrate (sandostene) in dermatological disorders". Canadian Medical Association Journal. 80 (6): 445–448. PMC 1830689. PMID 13629433.
- "Thenalidine". DrugBank.
Antihistamines for topical use | |
---|---|
Anesthetics for topical use | |
Others |
|
Benzimidazoles (*) | |
---|---|
Diarylmethanes |
|
Ethylenediamines | |
Tricyclics | |
Others |
|
For topical use |
Histamine receptor modulators | |
---|---|
H1 |
|
H2 |
|
H3 |
|
H4 |
|
See also: Receptor/signaling modulators • Monoamine metabolism modulators • Monoamine reuptake inhibitors |
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.